What Is (acetyl-CoA carboxylase) kinase

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 10, 2026

Quick Answer: Acetyl-CoA carboxylase (ACC) kinase, primarily AMPK (AMP-activated protein kinase), is an enzyme that phosphorylates and deactivates ACC, a key enzyme in fatty acid synthesis. This mechanism regulates cellular energy metabolism, reducing fat production when energy levels are low. ACC kinase activity is crucial for metabolic health, weight management, and is being studied as a therapeutic target for obesity and type 2 diabetes.

Key Facts

AMPK phosphorylates ACC at specific threonine residues (Thr172 in ACC1, Thr265 in ACC2), causing a 95%+ reduction in enzyme activity within minutes
ACC kinase activity increases during energy stress conditions, when AMP/ATP ratios rise by just 2-3 fold, triggering cellular energy conservation
There are two ACC isoforms (ACC1 and ACC2) with distinct tissue distributions: ACC1 primarily in liver and adipose tissue, ACC2 in heart, skeletal muscle, and brain
Studies show that activating ACC kinase can reduce body weight by 10-15% in animal models and improve insulin sensitivity by 20-30%
The AMPK-ACC pathway has been investigated since the 1980s and remains one of the most promising targets for metabolic disease therapeutics in clinical development

Overview

Acetyl-CoA carboxylase (ACC) kinase refers to enzymes, most notably AMP-activated protein kinase (AMPK), that phosphorylate and regulate acetyl-CoA carboxylase. ACC is a crucial enzyme in lipid metabolism that catalyzes the conversion of acetyl-CoA to malonyl-CoA, the first committed step in fatty acid synthesis. By phosphorylating ACC, these kinases effectively shut down fat production and redirect cellular energy toward energy-generating pathways.

This regulatory mechanism is fundamental to metabolic homeostasis, allowing cells to sense energy availability and adjust biosynthetic processes accordingly. When energy is abundant, ACC remains active and fatty acids are synthesized. Conversely, during energy stress or exercise, ACC kinase activation rapidly deactivates ACC, halting fatty acid synthesis and promoting fatty acid oxidation instead. This switching mechanism has made ACC kinase a major focus of metabolic research and pharmaceutical development.

How It Works

ACC kinase regulates cellular metabolism through a sophisticated phosphorylation mechanism:

Phosphorylation Activation: AMPK recognizes the energy-depleted state of the cell by sensing elevated AMP/ATP ratios, typically rising just 2-3 fold during stress conditions. This triggers AMPK activation and its translocation to ACC, where it phosphorylates specific threonine residues (Thr172 on ACC1 and Thr265 on ACC2) with remarkable precision.
Enzyme Inactivation: Phosphorylation causes a dramatic conformational change in ACC, reducing its enzymatic activity by approximately 95% within minutes. This rapid response allows cells to quickly halt malonyl-CoA production, the key substrate for fatty acid synthesis.
Metabolic Shift: With reduced malonyl-CoA levels, the inhibition of carnitine palmitoyltransferase-1 (CPT1) is relieved, permitting long-chain fatty acids to enter mitochondria for beta-oxidation and ATP generation. This shift from anabolic to catabolic metabolism is critical for energy conservation.
Tissue-Specific Effects: ACC kinase activity manifests differently across tissues because ACC1 (mainly in liver and adipose tissue) regulates fatty acid synthesis, while ACC2 (in heart, muscle, and brain) modulates fatty acid oxidation through CPT1 regulation. This tissue specificity allows fine-tuned metabolic control throughout the body.
Sustained Regulation: Phosphorylation is reversible when AMPK activity decreases and phosphatase activity increases, allowing ACC to be reactivated when energy availability improves. This dynamic regulation ensures flexible metabolic responses to changing cellular conditions.

Key Comparisons

Aspect	ACC Kinase (AMPK)	Other ACC Regulators
Primary Trigger	AMP/ATP ratio elevation during energy stress	Hormonal signals (insulin, glucagon) or allosteric regulation
Speed of Action	Seconds to minutes (phosphorylation-based)	Minutes to hours (transcriptional or allosteric changes)
Specificity	Phosphorylates ACC at precise threonine residues	More general metabolic effects without direct ACC targeting
Reversibility	Reversible through phosphatase activity when energy improves	Often irreversible within short timeframes
Metabolic Scope	Coordinates energy conservation across multiple pathways simultaneously	May affect single metabolic branch

Why It Matters

Understanding and modulating ACC kinase activity has profound implications for human health and disease management:

Obesity and Weight Management: Experimental activation of ACC kinase in animal models reduces body weight by 10-15% and significantly improves metabolic parameters. This has led to intense pharmaceutical interest in developing ACC kinase activators as obesity therapeutics.
Type 2 Diabetes: Enhanced ACC kinase activity improves insulin sensitivity by 20-30% in preclinical studies by reducing hepatic lipid accumulation and improving pancreatic beta-cell function. Multiple clinical trials are evaluating ACC kinase activators for diabetes treatment.
Cardiovascular Health: ACC2 kinase activity in cardiac tissue promotes fatty acid oxidation and improves heart function, suggesting therapeutic potential for heart disease and heart failure management.
Metabolic Flexibility: ACC kinase activity enables metabolic flexibility—the ability to switch between glucose and fat oxidation based on availability. Loss of this flexibility underlies many metabolic diseases.

Since its discovery in the 1980s, the AMPK-ACC regulatory axis has emerged as one of the most conserved and important metabolic control mechanisms. Current pharmaceutical companies have invested billions in developing ACC kinase activators, with several candidates in human clinical trials. Understanding this fundamental metabolic switch continues to yield insights into aging, exercise physiology, and metabolic disease prevention.